Literature DB >> 10361237

Proviral load and immune function in blood and lymph node during HIV-1 and HIV-2 infection.

O Jobe1, K Ariyoshi, A Marchant, S Sabally, T Corrah, N Berry, S Jaffar, H Whittle.   

Abstract

Proviral load as well as lymphocyte phenotype and function were compared in peripheral blood and lymph node compartments of 17 HIV-1, 12 HIV-2 and three dually infected patients with lymphadenopathy. The mean percentage (95% confidence interval (CI)) of CD4+ cells was higher in lymph node mononuclear cells (LNMC) than in peripheral blood mononuclear cells (PBMC) in both infections, being 26.7% (21. 1%, 32.3%) and 15.3% (10.4%, 20.2%), respectively, for HIV-1-infected patients (P = 0.0001) and 32.3% (22.7%, 41.9%) and 22. 1% (13.6%, 30.6%), respectively, for HIV-2-infected patients (P = 0. 02). In both types of infection, proviral load adjusted for number of CD4+ cells was higher in LNMC than in PBMC: the geometric mean (95% CI) was 8937 (4991; 16 003) and 4384 (2260; 8503), respectively, for HIV-1 patients (P = 0.02) and 1624 (382; 6898) and 551 (147; 2058) DNA copies, respectively, for HIV-2 patients (P = 0.05). Proviral load in both compartments was closely correlated (HIV-1, r = 0.60, P = 0.01; and HIV-2, r = 0.83, P = 0.0003). In both infections, proliferation and interferon-gamma (IFN-gamma) production in response to purified protein derivative (PPD) was lower in LNMC than in PBMC, both of which, in turn, were lower than in healthy controls. These results indicate that in HIV-2 as in HIV-1 infection, infected cells have a tropism for the lymph nodes resulting in higher viral load in this compartment and lower lymphocyte responses to the recall antigen PPD which may increase susceptibility to tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10361237      PMCID: PMC1905295          DOI: 10.1046/j.1365-2249.1999.00914.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  HIV-2-induced immunosuppression among asymptomatic West African prostitutes: evidence that HIV-2 is pathogenic, but less so than HIV-1.

Authors:  J Pepin; G Morgan; D Dunn; S Gevao; M Mendy; I Gaye; N Scollen; R Tedder; H Whittle
Journal:  AIDS       Date:  1991-10       Impact factor: 4.177

2.  Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.

Authors:  H C Lane; J M Depper; W C Greene; G Whalen; T A Waldmann; A S Fauci
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

3.  High viral burden in lymph nodes during early stages of HIV-1 infection.

Authors:  A Lafeuillade; C Tamalet; P Pellegrino; C Tourres; N Yahi; C Vignoli; R Quilichini; P de Micco
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

4.  Immunological responses of Gambians in relation to clinical stage of HIV-2 disease.

Authors:  H Whittle; A Egboga; J Todd; G Morgan; M Rolfe; S Sabally; A Wilkins; T Corrah
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

Review 5.  HIV-1 infection in the lymphoid organs.

Authors:  C Graziosi; G Pantaleo; J F Demarest; O J Cohen; M Vaccarezza; L Butini; M Montroni; A S Fauci
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

6.  Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA.

Authors:  C H Fox; K Tenner-Rácz; P Rácz; A Firpo; P A Pizzo; A S Fauci
Journal:  J Infect Dis       Date:  1991-12       Impact factor: 5.226

Review 7.  T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function?

Authors:  L Meyaard; H Schuitemaker; F Miedema
Journal:  Immunol Today       Date:  1993-04

8.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.

Authors:  G Pantaleo; C Graziosi; J F Demarest; L Butini; M Montroni; C H Fox; J M Orenstein; D P Kotler; A S Fauci
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

9.  Cellular and plasma viral load in patients infected with HIV-2.

Authors:  F Simon; S Matheron; C Tamalet; I Loussert-Ajaka; S Bartczak; J M Pépin; C Dhiver; E Gamba; C Elbim; J A Gastaut
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

Review 10.  The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses.

Authors:  S A Kalams; B D Walker
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  5 in total

1.  FDC:TFH Interactions within Cervical Lymph Nodes of SIV-Infected Rhesus Macaques.

Authors:  Rajnish S Dave; Ravi K Sharma; Roshell R Muir; Elias Haddad; Sanjeev Gumber; Francois Villinger; Artinder P Nehra; Zafar K Khan; Brian Wigdahl; Aftab A Ansari; Siddappa N Byrareddy; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2017-12-29       Impact factor: 4.147

2.  HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication.

Authors:  S M Fernandes; A R Pires; P Matoso; C Ferreira; H Nunes-Cabaço; L Correia; E Valadas; J Poças; P Pacheco; H Veiga-Fernandes; R B Foxall; A E Sousa
Journal:  Mucosal Immunol       Date:  2017-05-17       Impact factor: 7.313

3.  Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does not protect against disease progression.

Authors:  Jérôme Feldmann; Aleksandra Leligdowicz; Assan Jaye; Tao Dong; Hilton Whittle; Sarah L Rowland-Jones
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

4.  Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV disease.

Authors:  Rita Cavaleiro; António P Baptista; Rui S Soares; Rita Tendeiro; Russell B Foxall; Perpétua Gomes; Rui M M Victorino; Ana E Sousa
Journal:  PLoS Pathog       Date:  2009-11-20       Impact factor: 6.823

5.  The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.

Authors:  Pedro Borrego; José Maria Marcelino; Cheila Rocha; Manuela Doroana; Francisco Antunes; Fernando Maltez; Perpétua Gomes; Carlos Novo; Helena Barroso; Nuno Taveira
Journal:  Retrovirology       Date:  2008-09-08       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.